Literature DB >> 12730438

Underwood Memorial Lecture: human zinc homeostasis: good but not perfect.

Michael Hambidge1.   

Abstract

Three selected aspects of human zinc homeostasis and requirements are reviewed with special reference to studies undertaken by the author and his colleagues: 1) the implications for the calculation of physiologic requirements for zinc of the interrelationship between two key variables of zinc homeostasis, intestinal excretion of endogenous zinc and total absorbed zinc, are examined at levels of absorption below those necessary to meet physiologic requirements; 2) a method for deriving average dietary zinc requirements from zinc-stable isotope tracer/metabolic studies is illustrated with examples of studies being conducted in developing countries; and 3) the effect of reduction of high intakes of phytic acid on zinc bioavailability is examined with test meals prepared from low-phytic-acid maize or isohybrid wild-type control maize.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730438     DOI: 10.1093/jn/133.5.1438S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

Review 1.  Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.

Authors:  Mary E Aronow; Emily Y Chew
Journal:  Curr Opin Ophthalmol       Date:  2014-05       Impact factor: 3.761

Review 2.  What do we know about the macular pigment in AMD: the past, the present, and the future.

Authors:  Ranganathan Arunkumar; Charles M Calvo; Christopher D Conrady; Paul S Bernstein
Journal:  Eye (Lond)       Date:  2018-03-26       Impact factor: 3.775

3.  Measurement of zinc absorption from meals: comparison of extrinsic zinc labeling and independent measurements of dietary zinc absorption.

Authors:  Xiao-Yang Sheng; K Michael Hambidge; Leland V Miller; Jamie E Westcott; Sian Lei; Nancy F Krebs
Journal:  Int J Vitam Nutr Res       Date:  2009-07       Impact factor: 1.784

4.  Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

Authors:  Emily Y Chew; Traci E Clemons; John Paul Sangiovanni; Ronald P Danis; Frederick L Ferris; Michael J Elman; Andrew N Antoszyk; Alan J Ruby; David Orth; Susan B Bressler; Gary E Fish; George Baker Hubbard; Michael L Klein; Suresh R Chandra; Barbara A Blodi; Amitha Domalpally; Thomas Friberg; Wai T Wong; Philip J Rosenfeld; Elvira Agrón; Cynthia A Toth; Paul S Bernstein; Robert D Sperduto
Journal:  JAMA Ophthalmol       Date:  2014-02       Impact factor: 7.389

5.  The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).

Authors:  Emily Y Chew; Traci Clemons; John Paul SanGiovanni; Ronald Danis; Amitha Domalpally; Wendy McBee; Robert Sperduto; Frederick L Ferris
Journal:  Ophthalmology       Date:  2012-07-26       Impact factor: 12.079

6.  Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.

Authors:  Emily Y Chew; John Paul SanGiovanni; Frederick L Ferris; Wai T Wong; Elvira Agron; Traci E Clemons; Robert Sperduto; Ronald Danis; Suresh R Chandra; Barbara A Blodi; Amitha Domalpally; Michael J Elman; Andrew N Antoszyk; Alan J Ruby; David Orth; Susan B Bressler; Gary E Fish; George B Hubbard; Michael L Klein; Thomas R Friberg; Philip J Rosenfeld; Cynthia A Toth; Paul Bernstein
Journal:  JAMA Ophthalmol       Date:  2013-07       Impact factor: 7.389

Review 7.  Nutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry Eye.

Authors:  Ronald P Hobbs; Paul S Bernstein
Journal:  J Ophthalmic Vis Res       Date:  2014 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.